[Not Available].
作者信息
Srivastava Anita, Kahan Meldon, Nader Maya
机构信息
Professeure agrégée au Département de médecine familiale et communautaire de l'Université de Toronto, en Ontario, et membre de la St Joseph's Urban Family Health Team, à Toronto.
Professeur agrégé au Département de médecine familiale et communautaire de l'Université de Toronto et directeur médical du Service de toxicomanie à l'Hôpital Women's College à Toronto.
出版信息
Can Fam Physician. 2017 Mar;63(3):e153-e159.
Abstract
摘要
相似文献
1
[Not Available].
Can Fam Physician. 2017 Mar;63(3):e153-e159.
本文引用的文献
1
Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.
Can Fam Physician. 2017 Feb;63(2):137-145.
2
Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone.
SAGE Open Med. 2014 Apr 15;2:2050312114530282. doi: 10.1177/2050312114530282. eCollection 2014.
3
4
Buprenorphine and naloxone compared with methadone treatment in pregnancy.
Obstet Gynecol. 2015 Feb;125(2):363-368. doi: 10.1097/AOG.0000000000000640.
5
Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
JAMA Intern Med. 2014 Dec;174(12):1947-54. doi: 10.1001/jamainternmed.2014.5302.
6
The burden of premature opioid-related mortality.
Addiction. 2014 Sep;109(9):1482-8. doi: 10.1111/add.12598. Epub 2014 Jul 7.
7
A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.
J Addict Med. 2014 May-Jun;8(3):176-82. doi: 10.1097/ADM.0000000000000035.
8
Maintenance agonist treatments for opiate-dependent pregnant women.
Cochrane Database Syst Rev. 2013 Dec 23(12):CD006318. doi: 10.1002/14651858.CD006318.pub3.
9
Regaining control: the patient experience of supervised compared with unsupervised consumption in opiate substitution treatment.
Drug Alcohol Rev. 2014 Jan;33(1):64-70. doi: 10.1111/dar.12079. Epub 2013 Nov 20.
10
A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.
JAMA Psychiatry. 2013 Dec;70(12):1347-54. doi: 10.1001/jamapsychiatry.2013.2216.
Zotero 插件